Valerie Legagneur brings 20+ years of clinical research experience to her role as AVEO’s Vice President of Clinical Operations. Prior to joining AVEO’s management team, Ms. Legagneur led up the Clinical Operations group as Vice President, Clinical Operations at Odonate Therapeutics Inc. Ms. Legagneur also worked at Pfizer Inc. for 10+ years in various roles of increasing responsibility within Development Operations. In her last role at Pfizer she served as the Director, Clinical Operations Program Lead for the Hematology / Oncology Portfolio. During her time at Pfizer she led several Clinical Operations teams that supported the clinical trial executions leading to approvals for IBRANCE™ and BESPONSA™. Ms. Legagneur received both BA and MA degrees from State University of New York at Stony Brook.